<SEC-DOCUMENT>0001213900-17-003417.txt : 20170406
<SEC-HEADER>0001213900-17-003417.hdr.sgml : 20170406
<ACCEPTANCE-DATETIME>20170406121318
ACCESSION NUMBER:		0001213900-17-003417
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20170405
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170406
DATE AS OF CHANGE:		20170406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OptimizeRx Corp
		CENTRAL INDEX KEY:			0001448431
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				261265381
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-53605
		FILM NUMBER:		17745049

	BUSINESS ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
		BUSINESS PHONE:		248-651-6558

	MAIL ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k040517_optimizerxcorp.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO SECTION 13 OR 15(d) OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
SECURITIES EXCHANGE ACT OF 1934</B><BR>
<BR>
Date of Report (Date of earliest event reported): April 5, 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>OptimizeRx
Corporation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-decoration: none">
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada</FONT></TD>
    <TD STYLE="width: 2%; padding: 0 0 1.5pt; text-align: center; font: 10pt Times New Roman, Times, Serif; text-decoration: none"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-53605</FONT></TD>
    <TD STYLE="width: 2%; padding: 0 0 1.5pt; text-align: center; font: 10pt Times New Roman, Times, Serif; text-decoration: none"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26-1265381</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction<BR>
of incorporation)</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
    <BR>
File Number)</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer<BR>
Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-decoration: none">
    <TD STYLE="width: 49%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">400
    Water Street, Suite 200, Rochester, MI</FONT></TD>
    <TD STYLE="width: 2%; padding: 0 0 1.5pt; text-align: center; font: 10pt Times New Roman, Times, Serif; text-decoration: none"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 49%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48307</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&rsquo;s
telephone number, including area code: <U>248-651-6568</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 60%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 4%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="width: 96%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify">&#9744;</TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify">&#9744;</TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
8 &ndash; Other Events</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 10%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
                                         8.01</B></FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
                                         Events</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 5, 2017, we issued a press release concerning our partnership with SingleCare Services, LLC. A copy of the press release
is attached as Exhibit 99.1 to this Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in Item 8.01 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed &ldquo;filed&rdquo; for
purposes of Section 18 of the Securities Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;) or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange
Act, except as expressly set forth by specific reference in such a filing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9 &ndash; Financial Statements and Exhibits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 10%; padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
                                         9.01</B></FONT></TD><TD STYLE="padding: 0; text-indent: 0; font: 10pt Times New Roman, Times, Serif; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
                                         Statements and Exhibits</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; background-color: rgb(204,238,255)">
<TD STYLE="width: 8%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD><TD STYLE="text-align: justify; width: 92%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press
release, dated April 5, 2017</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OptimizeRx
Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 40%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Doug Baker</FONT></TD>
    <TD STYLE="width: 60%; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Doug
    Baker<BR>
    Chief Financial Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    April 6, 2017</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>f8k040517ex99i_optimizerx.htm
<DESCRIPTION>PRESS RELEASE, DATED APRIL 5, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; padding: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; padding: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-indent: 4in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 40%"><IMG SRC="ex99i_001.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 40%"><IMG SRC="ex99i_002.jpg" ALT=""></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-indent: 4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OptimizeRx
Partners Exclusively with SingleCare to Bring Patient <BR>
Savings and Price Transparency to Healthcare Providers at the <BR>
Point of Prescribe</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COLUMBUS,
Ohio and ROCHESTER, Mich., April 5, 2017</B> &ndash; SingleCare Services, LLC, the leading provider of prescription savings programs,
has partnered with OptimizeRx Corp. (OTCQB: OPRX), the leading aggregator of sponsored services in the electronic health records
(EHR) space. The exclusive partnership provides OptimizeRx clients the opportunity to connect their customers with the right drug,
at the right time, at the right price, through SingleCare&rsquo;s prescription savings program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
integration of SingleCare&rsquo;s pharmacy offering with OptimizeRx&rsquo;s platform will allow healthcare providers to offer
guaranteed savings to their patients without any interruption in their e-prescribe workflow. Through the OptimizeRx platform,
SingleCare&rsquo;s prescription savings program can be electronically transmitted with an e-Prescription to the pharmacy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;SingleCare
is always looking for opportunities to help improve patient outcomes,&rdquo; said Rick Bates, CEO and co-founder of SingleCare.
&ldquo;In partnership with OptimizeRx, we will be able to deliver prescription savings to more than 500,000 healthcare professionals
and their patients. Healthcare professionals spend more than three hours a day using their EHR; our ability to connect with them
during their regular workflow improves their efficiency and creates significant value for their patients.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SingleCare
negotiates the lowest possible pricing on all FDA-approved prescription medications and then passes the value through to consumers.
SingleCare also offers industry leading pricing tools, where consumers can see the cost of their prescriptions at in-network pharmacies.
SingleCare is accepted nationwide at over 35,000 retail pharmacies, including Walmart, CVS, Walgreens, Kroger, Target, Longs Drugs,
Fry&rsquo;s, Duane Reade and Harris Teeter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;The
SingleCare prescription savings program will be an excellent addition for our extensive network of more than 350 EHR/eRx network
partners,&rdquo; said William Febbo, CEO of OptimizeRx. &ldquo;In an expensive healthcare environment, patient empowerment is
important and valued. The uniqueness of our SingleCare partnership provides prescription price transparency to consumers, which
encourages patient compliance and reduction in prescription abandonment. That means better overall health outcomes, a core commitment
of OptimizeRx.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
SingleCare</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SingleCare,
a 2016 Dig|Benefits Technology Innovator Award winner, is reshaping the way we think about healthcare by creating an online, price
transparent marketplace for the purchase of routine health services. SingleCare offers pre-negotiated, affordable rates for routine
care and publishes those rates so consumers can make more informed decisions about their healthcare and the subsequent costs.
With an intuitive online platform and free membership, consumers can see a medical doctor online or search, view, and compare
the cost of dental procedures, vision exams, and prescriptions; book an appointment&ndash;and then pay the pre-negotiated rate
after their appointment. For healthcare providers, SingleCare guarantees full payment for services rendered so they can reduce
financial risk, administrative burdens and cost. Founded in 2014, SingleCare is headquartered in Columbus, Ohio. Learn more at
<U>www.singlecare.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
OptimizeRx Corp</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
in Rochester, Michigan, OptimizeRx Corporation is a health technology software company that is revolutionizing the point of care
experience through technology to improve clinical decisions and outcomes. OptimizeRx&rsquo;s unique consumer and physician platforms
help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare
companies effective ways to expand awareness, access and adherence to their medications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
OptimizeRx core product replaces drug samples with electronic trial vouchers and copay coupon savings that are electronically
added to an e-Prescription and sent electronically to the pharmacy and is integrated within leading electronic health record (EHR)
platforms in the country, including Allscripts, DrFirst, NewCrop, Quest Diagnostics, Practice Fusion and other EHRs to reach over
500,000 healthcare providers. In turn, OptimizeRx promotes patient savings and support from the world&rsquo;s largest pharmaceutical
companies, including Pfizer, Lilly, Novartis, AstraZeneca, and many others. For more information, visit <U>www.optimizerx.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Important
Cautions Regarding Forward Looking Statements</B><BR>
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as
amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make
an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements,
which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any
forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently
subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ
materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties
to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition
and other material risks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SingleCare&rsquo;s
Media Contact: </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rich
Shea</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shea
Communications</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
(212) 627-5766</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>rshea@sheacommunications.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OptimizeRx&rsquo;s
Investor Relations Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ron
Both</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CMA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
(949) 432-7557</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>oprx@cma.team</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="margin: 0; padding: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99i_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99i_001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ] /0# 2(  A$! Q$!_\0
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MOP_9C33XK.C11RZY\,/BIHJ%XW!CE0CPU#(\?C4DA9"R,!]?EW!G@]QPEE'
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M?IG(]!7Y5^&?B)^SU^SAX1T[Q!\,S<?$OXC^+])!?5M4*V$FE#8Q,6N;D/\
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M\'EQBOTJ_P""5'_!O9#^S)\2/"W[2/[6GBKP[X^^)W@YQK'P\^%OA=#?>!_
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M%GU7<@&BGPZ(CXB92"#YRQ\X,@^]7];SQ;UE3I\H7GU('^&?PKP3Q=^T_P#
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%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99i_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99i_002.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ] 1<# 2(  A$! Q$!_\0
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MEJ.I-)!X!^(LL+$O^\0AE(418+$J6 VJ!^0+>//!TFV23Q-HPC!P62[(4\]
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MB:\"= 7&<K@AONGY210!_3G1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ?R$_P#!6G]O[QG\1?B=XN_9A^$?B&^\/_"OP!='PW\0+G1KY;"[\?\
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M%)>YRQ5F^5<S9^!D<,;Q232R;<9"J,%G;' Q_D#C/%?V"?\ !)O]D+4/A?\
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MM-*@)U7^P5UG6FT?Q3XK\+:_H;:Z^B+XN?PI=6_B_P %GQ'&T_@EX5 'VO\
M\%O_ -M[X]?L(_LX?#CXG_L]WGA/3O%'B?XOV'@K5[OQ=X=;Q%I:Z5+X1\2>
M('_=9 5C_8842XWE00K ;@?R8TO_ (+7_L7?MG>*? 7P@_X*3_L-:=H=GHOB
M2+^R_%FLWI\<>%?ASJVLD:$VNZ]X?U[PWX/\2>&]"E3<KRQ+XNS\K.C^5&H^
MI/\ @YXCLH_V)/@5!9"%;$?M"Z4MJ+;[HTT?#'Q]DIU!&"""."""?FW4DO\
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M/AGXP:EX)MO^$,\//X=TO^R(_!/@/7HG6-FP\BW&O:L"^/,8%59SB,#\]/\
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MU71=)UHRS1Z'I4*;$FO%8O)(K%&$>T#\JKR\OM1NKB^OKZYU*XN@?]+N[O\
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MX-^%_@'X0Z1I#>(->TL>(O$4$,C2^*HWD\)+(B0O*D\Y\&F[D,<B>Z_L4?\
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J06B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
